Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system

25 August 2023 (11:15 - 11:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Qian Ma

Beijing Anzhen Hospital, Beijing (China)

6 More presentations in this session

Presentation thumbnail

Risk of myocardial infarction following capecitabine treatment in patients with gastrointestinal cancer - a nationwide registry-based study

Doctor J. Shanmuganathan (Aalborg, DK)

Abstract Slides Video

Presentation thumbnail

Combination of nicorandil and beta-adrenergic receptor blockers in patients with coronary heart disease: a real-world observational study

Professor N. Zhou (Wuhan, CN)

Abstract Slides Video

Presentation thumbnail

Cardioprotective potential of exosomes derived from blood outgrowth endothelial cells in ischemic cardiomyopathy

Doctor M. Wu (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

PSRC1 rs599839 G allele may promote protection from coronary artery disease in a Madeira Island population

Mr F. Sousa (Funchal, PT)

Abstract Slides Video

Presentation thumbnail

Effects on re-endothelialisation with Bydureon treatment add on to insulin versus insulin alone, both in combination with metformin in type 2 diabetic subjects: Rebuild study

Doctor I. Santos-Pardo (Badalona, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Drug-related risk management in chronic coronary syndromes

The Event

Event poster

ESC Congress 2023

25 August 2023 11:15 CET

You may be interested in

Congress Session

Novel drugs for cardiovascular diseases

Congress Presentation

Inhibition of ceramide de novo synthesis mitigates atherosclerosis

Congress Session

Atherosclerosis: prevention and new regression

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources